Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Genetic Testing Reduces Risks From Chemotherapy for Gastrointestinal Cancer Patients

For some patients with gastrointestinal (GI) cancers like colorectal and pancreatic cancer, chemotherapy can cause severe, sometimes life-threatening side effects in those who carry certain genetic variants that can impact how their bodies process the drugs used to treat their disease. Testing for variants in two genes before starting chemotherapy can significantly improve patient safety by providing physicians with information to help tailor doses, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Those who were found to have one of the genes had half as many side effects in half, as compared to patients with the genes that were given standard doses without testing, according to results published today in JCO Precision Oncology.

August 7, 2025


August 8 2025

August 7 2025

August 6 2025

August 5 2025

August 4 2025

August 3 2025

August 2 2025

August 1 2025

July 31 2025

July 30 2025

July 29 2025

July 28 2025

July 26 2025

July 25 2025